NIVF vs WORX

NIVF exhibits a catastrophic price collapse (-99.8% over 1 year) and severe operational dysfunction. While the Piotroski F-Score of 5/9 suggests baseline stability, this is heavily skewed by a non-operating profit spike, as evidenced by a 209.03% profit margin contrasted against a disastrous -349.13% operating margin. The company is fundamentally unable to generate profit from its core medical care facilities. The massive discrepancy between the current price ($2.19) and the single analyst's target price ($900) indicates a complete breakdown in valuation reliability.

SCWorx Corp exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is experiencing a catastrophic price collapse, with a 5-year decline of 99.7% and a recent 1-month drop of 47.5%. Despite a low debt-to-equity ratio and modest revenue growth of 13.8%, the profit margin of -154.44% and an ROE of -76.35% demonstrate an unsustainable business model that is rapidly eroding shareholder equity.